Bioética clínica. Lineamientos sobre el inicio y la suspensión del tramatiento de hemodiálisis

[Autom. eng. transl.] The decision about access or suspension of dialysis treatment in patients with chronic renal failure (CRL) currently revolves around the recognition of those patients for whom it is not indicated. Therefore, the initial question according to which it was necessary to ensure treatment to all the many patients who could have benefited from it, has been alternated by an opposite problem: to identify, among the many candidates for dialysis, those who would not obtain an appreciable benefit. Where, in fact, the treatment is not capable of offering the expected medical benefits, configuring a true and proper medical futility or, where the weight imposed by the treatment (side effects, complications, etc.) exceeds the benefits that this is capable of offering the patient, it is ethically appropriate not to start (or eventually suspend) the treatment itself.